Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 5, 2009, Pages

  Kramer, Andrea B ^a   Van Timmeren, Mirjan M ^a   Schuurs, Theo A ^a   Vaidya, Vishal S ^b   Bonventre, Joseph V ^b   Van Goor, Harry ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ACE inhibitors; Chronic kidney disease; Fibrosis; Proteinuria; Proximal tubule

Indexed keywords

DOXORUBICIN; KIDNEY INJURY MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 66049115451     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00541.2007     Document Type: Article

References (43)

1. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277: 39739-39748, 2002. (Pubitemid 35190957)
2. Barbey MM, Fels LM, Soose M, Poelstra K, Gwinner W, Bakker W, Stolte H. Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals. Free Radic Res Commun 7: 195-203, 1989. (Pubitemid 19281966)
3. Bertani T, Cutillo F, Remuzzi G. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30: 488-496, 1986. (Pubitemid 16000793)
4. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16-23, 1982. (Pubitemid 12167012)
5. Bonventre JV. Kidney injury molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 241: 78-83, 2008.
6. Bos H, Henning RH, De Boer E, Tiebosch ATM, De Jong PE, De Zeeuw D, Navis GJ. Addition of AT1 blocker fails to overcome resistance to ACE-i in adriamycin nephrosis. Kidney Int 61: 473-480, 2002. (Pubitemid 34102587)
7. Cao Z, Cooper ME. Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 21: 554-562, 2001. (Pubitemid 33091937)
8. De Boer E, Navis GJ, Tiebosch ATM, De Jong PE, De Zeeuw D. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol 10: 2359-2366, 1999. (Pubitemid 29501469)
9. de Borst MH, van Timmeren MM, Vaidya VS, de Boer RA, Van Dalen MB, Kramer AB, Schuurs TA, Bonventre JV, Navis G, van Goor H. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 292: F313-F320, 2007. (Pubitemid 46105271)
10. Deelman LE, Navis G, de Boer E, Wietses M, de Zeeuw D, Henning RH. Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats. J Renin Angiotensin Aldosterone Syst 4: 38-42, 2003. (Pubitemid 36443385)
11. Dukacz SA, Adams MA, Kline RL. Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 276: R10-R16, 1999.
12. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 9: 1418-1425, 1994. (Pubitemid 24310284)
13. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118: 1657-1668, 2008.
14. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is upregulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998. (Pubitemid 28103282)
15. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 286: F552-F563, 2004. (Pubitemid 38233650)
16. Jeansson M, Bjorck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol 20: 114-122, 2009.
17. Klahr S, Morrissey JJ. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 52: S111-S114, 1997. (Pubitemid 28020447)
18. Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, Butte MJ, Nagumo H, Chernova I, Zhu B, Sharpe AH, Ito S, Dranoff G, Kaplan GG, Casasnovas JM, Umetsu DT, Dekruyff RH, Freeman GJ. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940, 2007. (Pubitemid 50014866)
19. Kramer AB, Bos H, van Goor H, Navis GJ. Sodium intake modifies the negative prognostic value of renal damage prior to treatment with ACE inhibitors on proteinuria induced by adriamycin. Nephron Physiol 103: 43-52, 2006.
20. Kramer AB, Laverman GD, van Goor H, Navis G. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage. J Pathol 201: 160-167, 2003. (Pubitemid 37121215)
21. Kramer AB, van der Meulen EF, Hamming I, van Goor H, Navis G. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int 71: 417-424, 2007. (Pubitemid 46303564)
22. Kuehn EW, Park KM, Somlo S, Bonventre JV. Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 283: F1326-F1336, 2002. (Pubitemid 35332662)
23. Lufft V, Kliem V, Hamkes A, Bleck JS, Eisenberger U, Brunkhorst R. Antiproteinuric efficacy of fosinopril after renal transplantation. Clin Transpl 12: 409-415, 1998.
24. Perico N, Cattaneo D, Remuzzi G. Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression. Am J Kidney Dis 53: 1-4, 2009.
25. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984. (Pubitemid 14017051)
26. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensin- aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl: S57-S65, 2005. (Pubitemid 44324688)
27. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354: 359-364, 1999. (Pubitemid 29355751)
28. Ruggenenti P, Perna A, Remuzzi G. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 63: 2254-2261, 2003. (Pubitemid 36605839)
29. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron 55: 242-250, 1990. (Pubitemid 20103999)
30. Smit-van Oosten A, Navis G, Stegeman CA, Joles JA, Klok PA, Kuipers F, Tiebosch AT, van Goor H. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. J Pathol 194: 122-129, 2001.
31. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290: F517-F529, 2006. (Pubitemid 43725006)
32. Vaidya V, Ramirez V, Bobadilla N, Bonventre J. A microfluidics based assay to measure kidney injury molecule-1 (Kim-1) in the urine as a biomarker for early diagnosis of acute kidney injury (Abstract). J Am Soc Nephrol 16: 192A, 2005.
33. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 291: F456-F464, 2006. (Pubitemid 44148135)
34. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries APJ, Gans ROB, van Goor H, Stegeman CA, Bonventre JV, Bakker SJL. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84: 2007.
35. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212: 209-217, 2007. (Pubitemid 46852099)
36. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 53: 16-25, 2009.
37. Wapstra FH, van Goor H, de Jong PE, Navis G, de Zeeuw D. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis. J Pharmacol Toxicol Methods 41: 69-73, 1999. (Pubitemid 29531517)
38. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner HV. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 31: 67-76, 1989. (Pubitemid 19061039)
39. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33: 115-122, 1990. (Pubitemid 20103999)
40. Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 73: 608-614, 2008.
41. Zhang Z, Humphreys BD, Bonventre JV. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 18: 2704-2714, 2007. (Pubitemid 47531197)
42. Zoja C, Benigni A, Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 13: 31-37, 2004. (Pubitemid 39069896)
43. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53: 1608-1615, 1998. (Pubitemid 28243743)